![]()
yahoo | Data Presented at ECTRIMS 2018 Show Potential of MOSPD2 as a Novel Target for Treatment of CNS Inflammation, Such as Multiple Sclerosis |
yahoo | Edited Transcript of VBLT earnings conference call or presentation 16-Aug-18 12:30pm GMT |
yahoo | The Daily Biotech Pulse: No Anxiety For Biohaven, Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait |
yahoo | Vascular Biogenics Reports Q2 Loss, Lags Revenue Estimates |
yahoo | Vascular Biogenics: 2Q Earnings Snapshot |
yahoo | Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate |
yahoo | Edited Transcript of VBLT earnings conference call or presentation 17-May-18 12:30pm GMT |
yahoo | Vascular Biogenics Enters Oversold Territory |
zacks | Implied Volatility Surging for Vascular Biogenics Stock Options |
yahoo | VBL Therapeutics Awarded $2.5 Million Non-Dilutive Grant by the Israel Innovation Authority |
yahoo | Edited Transcript of VBLT earnings conference call or presentation 15-Mar-18 12:30pm GMT |
yahoo | VBL Therapeutics Announces Year End 2017 Financial Results |
marketwatch | Vascular Biogenics' stock plummets after brain cancer treatment trial fails |
yahoo | Does Vascular Biogenics Ltd’s CEO Pay Compared Well With Peers? |
yahoo | Vascular Biogenics Ltd : Is Healthcare An Attractive Sector Play? |
yahoo | What Falling Estimates & Price Mean for Vascular Biogenics |
yahoo | Why Vascular Biogenics Ltd. Is Tanking Today |
yahoo | Here’s Why Vascular Biogenics Ltd Stock Is Slumping Today |
reuters | VBL Therapeutics prices 2.5 million ordinary share offering |
yahoo | Edited Transcript of VBLT earnings conference call or presentation 14-Nov-17 1:30pm GMT |
yahoo | Vascular Biogenics reports 3Q loss |
reuters | VBL therapeutics Q3 loss per share $0.24 |
yahoo | Who Are The Major Shareholders Of Vascular Biogenics Ltd ? |
reuters | VBL Therapeutics and Nanocarrier signs agreement for VB-111 in Japan |
reuters | Nanocarrier signs exclusive agreement with VBL Therapeutics for VB-111 in Japan |
seekingalpha | Vascular Biogenics Stock May Shoot Up On The Back Of Upcoming Catalysts |
reuters | VBL THERAPEUTICS OPENS NEW GENE THERAPY MANUFACTURING PLANT, HEADQUARTERS |
